CLINDAMYCIN 1% / NIACINAMIDE 4% / TRETINOIN 0.05%
CLINDAMYCIN 1% / NIACINAMIDE 4% / TRETINOIN 0.05%
Approved
Approval ID
87fde97e-ac4e-e3da-e053-2a95a90a9b19
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 4, 2020
Manufacturers
FDA
Sincerus Florida, LLC
DUNS: 080105003
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
CLINDAMYCIN 1% / NIACINAMIDE 4% / TRETINOIN 0.05%
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72934-2054
Product Classification
G
Generic Name
CLINDAMYCIN 1% / NIACINAMIDE 4% / TRETINOIN 0.05%
Product Specifications
Route of AdministrationTOPICAL
Effective DateJune 4, 2020
FDA Product Classification
INGREDIENTS (3)
NIACINAMIDEActive
Quantity: 4 g in 100 g
Code: 25X51I8RD4
Classification: ACTIB
CLINDAMYCIN PHOSPHATEActive
Quantity: 1 g in 100 g
Code: EH6D7113I8
Classification: ACTIB
ALITRETINOINActive
Quantity: 0.05 g in 100 g
Code: 1UA8E65KDZ
Classification: ACTIB